Pfizer Reports Q3 Revenue of $16.6 Billion, Raises 2026 Guidance
Pfizer reported third-quarter 2026 revenue of $16.6 billion, relatively flat year over year operationally, and adjusted diluted EPS of $0.87. It raised full-year revenue guidance to $62.0 billion–$64.0 billion and adjusted diluted EPS guidance to $2.95–$3.05.
Story updates
01:22:10 PM UTC
SquawkNews
Pfizer reported third-quarter 2026 revenue of $16.58 billion, down 0.4% from a year earlier. Net income fell 8.4% to $3.24 billion, while diluted EPS declined 9.7% to $0.56.Financial Highlights¹ Reported as “Total revenues”. ² Reported as “Net income attributable to Pfizer Inc. common shareholders”…
Pfizer reported third-quarter 2026 revenue of $16.6 billion, relatively flat year over year operationally, and adjusted diluted EPS of $0.87. The company raised its full-year revenue guidance to $62.0 billion—$64.0 billion and adjusted diluted EPS guidance to $2.95—$3.05. Reported net income was $3…